Sandoz Group AG
SDZ
Pozycja w akcjach
#579
Operating globally, Sandoz Group AG specializes in the development, production,... Operating globally, Sandoz Group AG specializes in the development, production, and distribution of generic medications and biosimilar products. The company's portfolio includes the creation and sale of finished dosage forms for small molecule pharmaceuticals, often supplied to other entities. Sandoz is also a significant player in the biotechnology sector, providing protein-based products such as biosimilars and offering specialized manufacturing services within this field. Furthermore, it supplies anti-infective products, including active pharmaceutical ingredients (APIs) and intermediates, with a strong emphasis on antibiotics. Established in 1886, Sandoz maintains its headquarters in Rotkreuz, Switzerland.
Cena akcji
$96.18
Kapitalizacja rynkowa
$41.62B
Zmiana (1 dzień)
0.99%
Zmiana (1 rok)
58.93%
Kraj
CH
Handel Sandoz Group AG (SDZ)
Kategoria
Healthcare
Zyski dla Sandoz Group AG (SDZ)
Zyski w 2026 TTM: 0
Według najnowszych raportów finansowych Sandoz Group AG, obecny zysk firmy wynosi 0. W roku 2026 firma osiągnęła zysk w wysokości 0, równa się zysku z roku 2026, który wynosił 0. Wyświetlany zysk to zysk przed odsetkami i podatkami, czyli EBIT.
Historia zysków firmy Sandoz Group AG od 2020 do 2026
Zyski na koniec każdego roku
| Rok | Zyski | Zmień |
|---|---|---|
| 2025 | $1.21B | -11,072.73% |
| 2024 | $-11.00M | -108.46% |
| 2023 | $130.00M | -88.20% |
| 2022 | $1.10B | -15.20% |
| 2021 | $1.30B | 85.42% |
| 2020 | $700.85M | 0.00% |
Zyski podobnych firm lub konkurentów
| Firma | Zyski | Różnica w zyskach | Kraj |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $1.76B | - |
IN
|
